Last reviewed · How we verify
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM (PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM) — HaEmek Medical Center, Israel.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM TARGET | PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM | HaEmek Medical Center, Israel | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM CI watch — RSS
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM CI watch — Atom
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM CI watch — JSON
- PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM alone — RSS
Cite this brief
Drug Landscape (2026). PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM — Competitive Intelligence Brief. https://druglandscape.com/ci/preventive-treatment-sulfamethoxazole-and-trimethoprim. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab